Quick answers
- What is Imitrex?
- Imitrex is a brand name of Sumatriptan, a prescription medicine. The FDA NDC Directory lists 6 Imitrex products in 5 strengths and forms.
- Who makes Imitrex?
- Glaxosmithkline holds the FDA application for Imitrex (NDA020080, approved December 28, 1992).
- Is there a generic or store brand of Imitrex?
- Yes. The FDA NDC Directory lists 45 other products with the same active ingredients, strength and form as a Imitrex product, 45 of them generic. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Imitrex?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 3 Imitrex strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Imitrex been recalled?
- FDA enforcement reports list 1 recall of Imitrex products; the newest started November 6, 2013. A recall usually concerns specific lots, not every product.
What Imitrex is
Each Imitrex product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Sumatriptan · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| sumatriptan succinate 100 mg tablet, film coated (oral) | Imitrex | 8 products, 8 companies | DailyMed |
| sumatriptan succinate 25 mg tablet, film coated (oral) | Imitrex | 10 products, 7 companies | DailyMed |
| sumatriptan succinate 4 mg/0.5 mL injection (subcutaneous) | Imitrex | 2 products, 2 companies | DailyMed |
| sumatriptan succinate 50 mg tablet, film coated (oral) | Imitrex | 12 products, 10 companies | DailyMed |
| sumatriptan succinate 6 mg/0.5 mL injection (subcutaneous) | Imitrex | 13 products, 13 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Sumatriptan →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| sumatriptan succinate 100 mg tablet, film coated | Brand: Imitrex | $72.36 per tablet Generic of the same strength and form: $0.4378 per tablet |
| sumatriptan succinate 4 mg/0.5 mL injection | Brand: Imitrex | $463.54 per mL |
| sumatriptan succinate 6 mg/0.5 mL injection | Brand: Imitrex | $436.25–$459.40 per mL 2 packages, lowest to highest Generic of the same strength and form: $14.38–$59.41 per mL |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Imitrex
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Imitrex products.
- GlaxoSmithKline LLC6 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
November 6, 2013 · Class II · Terminated · D-387-2014
Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.
Imitrex STATdose System, Imitrex (sumatriptan succinate) Injection, 2 prefilled 0.5 mL syringe cartridges each containing 6 mg of sumatriptan for subcutaneous injection only, 1 imitrex STATdose Pen, 1 carrying case, Rx o — GlaxoSmithKline, LLC.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.